Exact Mass: 562.2333
Exact Mass Matches: 562.2333
Found 500 metabolites which its exact mass value is equals to given mass value 562.2333
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-(4-(5-Maleimidopentyl)aminobenzyl)ethylenediaminetetraacetic acid
thiamine disulfide
Berotralstat
B - Blood and blood forming organs > B06 - Other hematological agents > B06A - Other hematological agents > B06AC - Drugs used in hereditary angioedema D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
Baccharinol
3,3-Dihydroxy-5-methoxy-2,5,6-tris(4-hydroxybenzyl)bibenzyl
(2S,3R,4S,7R,9R,10S)-7-Deoxo-2-deoxy-2,3:9,10-diepoxy-9,10-dihydro-4-hydroxy-7-[(1R)-1-hydroxyethyl]verrucarin A
5alpha-acetoxy-1beta-benzoyl-8alpha-cinnamoyl-4alpha-hydroxydihydroagarofuran|5??-Acetoxy-1??-benzoyl-8??-cinnamoyl-4??-hydroxy-dihydroagarofuran
(19Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|19(Z)-burnamine-17-O-3,4,5-trimethoxybenzoate|burnamine-17-O-3,4,5-trimethoxybenzoate
(1R,2R,3R,4R,5S,7R,9S,10R)-3-acetoxy-1-benzoyloxy-9-cinnamoyloxy-2-hydroxydihydro-beta-agarofuran
(1R,2R,3R,4R,5S,7R,9S,10R)-2-acetoxy-1-benzoyloxy-9-cinnamoyloxy-3-hydroxydihydro-beta-agarofuran
(20R,22R)-15alpha-acetoxy-5alpha-chloro-16beta,17beta-epoxy-6beta,14beta-dihydroxy-1-oxo-witha-2,24-dienolide|physagulin I
(+)-Tiliacorine|ent-7,6-epoxy-6,12-dimethoxy-2(or 2)-methyl-rodiasan-12-ol|Isotiliarin|isotiliarine|nortiliacorine-A
1beta-(p-hydroxyphenylacetyl)-15-O-beta-D-glucopyranosyl-5alpha,6betaH-eudesma-3-en-12,6alpha-olide
3,3-dihydroxy-5-methoxy-2,6,6-tri(p-hydroxybenzyl)bibenzyl|pleiobibenzynin A
5beta-acetoxy-1alpha-benzoyl-9beta-cinnamoyl-4beta-hydroxydihydroagarofuran
9-O-butyl-3-O-demethyl-9-O-beta-D-glucopyranosyldehydrodiconiferyl alcohol
1beta-acetoxy-2beta-benzoxy-9alpha-beta-phenyloxacyclobutanoyloxy-beta-dihydroagarofuran|9-(2,3-Epoxycinnamoyl),2-benzoyl,1,2-di-Ac-1,2,9-Trihydroxydihydro-beta-agarofuran|9-(2,3-Epoxycinnamoyl),2-butanzoyl,1-Ac-(1alpha,2alpha,9beta)-1,2,9-Trihydroxdihydro-beta-agarofuran
2beta-acetoxy-1beta,8-diangeloyloxy-4alpha,10-dichloro-3beta,11-dihydroxybisabol-7(14)-ene
(5S)-1,7-bis-(3,4-dihydroxyphenyl)-5-hydroxy-3-heptanone-5-O-[2-(2-methylbutenoyl)]-beta-D-xylopyranoside|alnuside C
3,3-dihydroxy-5-methoxy-2,4,6-tri(4-hydroxybenzyl)bibenzyl
5-(10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl)-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol
5-(10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl)-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based on: CCMSLIB00000848685]
5-(10-hydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromen-5-yl)-7,9-dimethoxy-3-methyl-3,4-dihydro-1H-benzo[g]isochromene-4,10-diol [IIN-based: Match]
Ala Phe Tyr Tyr
Ala Thr Trp Trp
Ala Trp Thr Trp
Ala Trp Trp Thr
Ala Tyr Phe Tyr
Ala Tyr Tyr Phe
Cys Phe Phe Phe
Asp Asp Lys Trp
Asp Asp Trp Lys
Asp Gly Trp Trp
Asp Lys Asp Trp
Asp Lys Trp Asp
Asp Arg Ser Trp
Asp Arg Trp Ser
Asp Ser Arg Trp
Asp Ser Trp Arg
Asp Trp Asp Lys
Asp Trp Gly Trp
Asp Trp Lys Asp
Asp Trp Arg Ser
Asp Trp Ser Arg
Asp Trp Trp Gly
Glu Phe His Met
Glu Phe Met His
Glu His Phe Met
Glu His Met Phe
Glu Met Phe His
Glu Met His Phe
Glu Met Gln Arg
Glu Met Arg Gln
Glu Gln Met Arg
Glu Gln Arg Met
Glu Gln Thr Trp
Glu Gln Trp Thr
Glu Arg Met Gln
Glu Arg Gln Met
Glu Thr Gln Trp
Glu Thr Trp Gln
Glu Trp Gln Thr
Glu Trp Thr Gln
Phe Ala Tyr Tyr
Phe Cys Phe Phe
Phe Glu His Met
Phe Glu Met His
Phe Phe Cys Phe
Phe Phe Phe Cys
Phe Phe Ser Tyr
Phe Phe Tyr Ser
Phe His Glu Met
Phe His Met Glu
Phe His Pro Tyr
Phe His Tyr Pro
Phe Met Glu His
Phe Met His Glu
Phe Asn Pro Trp
Phe Asn Trp Pro
Phe Pro His Tyr
Phe Pro Asn Trp
Phe Pro Trp Asn
Phe Pro Tyr His
Phe Ser Phe Tyr
Phe Ser Tyr Phe
Phe Trp Asn Pro
Phe Trp Pro Asn
Phe Tyr Ala Tyr
Phe Tyr Phe Ser
Phe Tyr His Pro
Phe Tyr Pro His
Phe Tyr Ser Phe
Phe Tyr Tyr Ala
Gly Asp Trp Trp
Gly Trp Asp Trp
Gly Trp Trp Asp
His Glu Phe Met
His Glu Met Phe
His Phe Glu Met
His Phe Met Glu
His Phe Pro Tyr
His Phe Tyr Pro
His Ile Met Tyr
His Ile Tyr Met
His Leu Met Tyr
His Leu Tyr Met
His Met Glu Phe
His Met Phe Glu
His Met Ile Tyr
His Met Leu Tyr
His Met Tyr Ile
His Met Tyr Leu
His Pro Phe Tyr
His Pro Tyr Phe
His Tyr Phe Pro
His Tyr Ile Met
His Tyr Leu Met
His Tyr Met Ile
His Tyr Met Leu
His Tyr Pro Phe
Ile His Met Tyr
Ile His Tyr Met
Ile Met His Tyr
Ile Met Asn Trp
Ile Met Trp Asn
Ile Met Tyr His
Ile Asn Met Trp
Ile Asn Trp Met
Ile Trp Met Asn
Ile Trp Asn Met
Ile Tyr His Met
Ile Tyr Met His
Lys Asp Asp Trp
Lys Asp Trp Asp
Lys Trp Asp Asp
Met Glu Phe His
Met Glu His Phe
Met Glu Gln Arg
Met Glu Arg Gln
Met Phe Glu His
Met Phe His Glu
Met His Glu Phe
Met His Phe Glu
Met Gln Glu Arg
Met Gln Arg Glu
Met Arg Glu Gln
Met Arg Gln Glu
Met Ser Tyr Tyr
Met Tyr Ser Tyr
Met Tyr Tyr Ser
Asn Phe Pro Trp
Asn Phe Trp Pro
Asn Pro Phe Trp
Asn Pro Trp Phe
Asn Trp Phe Pro
Asn Trp Pro Phe
Pro Phe His Tyr
Pro Phe Asn Trp
Pro Phe Trp Asn
Pro Phe Tyr His
Pro His Phe Tyr
Pro His Tyr Phe
Pro Asn Phe Trp
Pro Asn Trp Phe
Pro Trp Phe Asn
Pro Trp Asn Phe
Pro Tyr Phe His
Pro Tyr His Phe
Gln Glu Met Arg
Gln Glu Arg Met
Gln Glu Thr Trp
Gln Glu Trp Thr
Gln Met Glu Arg
Gln Met Arg Glu
Gln Arg Glu Met
Gln Arg Met Glu
Gln Thr Glu Trp
Gln Thr Trp Glu
Gln Trp Glu Thr
Gln Trp Thr Glu
Arg Asp Ser Trp
Arg Asp Trp Ser
Arg Glu Met Gln
Arg Glu Gln Met
Arg Met Glu Gln
Arg Met Gln Glu
Arg Gln Glu Met
Arg Gln Met Glu
Arg Ser Asp Trp
Arg Ser Trp Asp
Arg Trp Asp Ser
Arg Trp Ser Asp
Ser Asp Arg Trp
Ser Asp Trp Arg
Ser Phe Phe Tyr
Ser Phe Tyr Phe
Ser Met Tyr Tyr
Ser Arg Asp Trp
Ser Arg Trp Asp
Ser Trp Asp Arg
Ser Trp Arg Asp
Ser Tyr Phe Phe
Ser Tyr Met Tyr
Ser Tyr Tyr Met
Thr Ala Trp Trp
Thr Glu Gln Trp
Thr Glu Trp Gln
Thr Gln Glu Trp
Thr Gln Trp Glu
Thr Trp Ala Trp
Thr Trp Glu Gln
Thr Trp Gln Glu
Thr Trp Trp Ala
Trp Ala Thr Trp
Trp Ala Trp Thr
Trp Asp Asp Lys
Trp Asp Gly Trp
Trp Asp Lys Asp
Trp Asp Arg Ser
Trp Asp Ser Arg
Trp Asp Trp Gly
Trp Glu Gln Thr
Trp Glu Thr Gln
Trp Phe Asn Pro
Trp Phe Pro Asn
Trp Gly Asp Trp
Trp Gly Trp Asp
Trp Lys Asp Asp
Trp Asn Phe Pro
Trp Asn Pro Phe
Trp Pro Phe Asn
Trp Pro Asn Phe
Trp Gln Glu Thr
Trp Gln Thr Glu
Trp Arg Asp Ser
Trp Arg Ser Asp
Trp Ser Asp Arg
Trp Ser Arg Asp
Trp Thr Ala Trp
Trp Thr Glu Gln
Trp Thr Gln Glu
Trp Thr Trp Ala
Trp Trp Ala Thr
Trp Trp Asp Gly
Trp Trp Gly Asp
Trp Trp Thr Ala
Tyr Ala Phe Tyr
Tyr Ala Tyr Phe
Tyr Phe Ala Tyr
Tyr Phe Phe Ser
Tyr Phe His Pro
Tyr Phe Pro His
Tyr Phe Ser Phe
Tyr Phe Tyr Ala
Tyr His Phe Pro
Tyr His Pro Phe
Tyr Met Ser Tyr
Tyr Met Tyr Ser
Tyr Pro Phe His
Tyr Pro His Phe
Tyr Ser Phe Phe
Tyr Ser Met Tyr
Tyr Ser Tyr Met
Tyr Tyr Ala Phe
Tyr Tyr Phe Ala
Tyr Tyr Met Ser
Tyr Tyr Ser Met
bis-(4-dimethylamino-phenyl)-phenyl-d5-carbenium picrate
1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-2-fluoro-β-D-arabinofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione
METHYL 2,3,4-TRI-O-ACETYL-6-O-TRIPHENYLMETHYL-BETA-D-GALACTOPYRANOSIDE
2-[[(3aS,4R,6S,6aR)-4-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-2,2-dimethyl-tetrahydro-3aH-cyclopenta[d][1,3]dioxol-6-yl]oxy]ethanol
Otilonium Bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D005765 - Gastrointestinal Agents Otilonium bromide (OB) is an orally active mAChR inhibitor and smooth muscle relaxant which can interfere with the mobilization of calcium in intestinal smooth muscle, OB can be used for research of irritable bowel syndrome[1][2][3].
3-[[(8α,9S)-6-Methoxycinchonan-9-yl]aMino]-4-[[4-(trifluoroMethyl)phenyl]aMino]-3-Cyclobutene-1,2-dione
Zinc,bis[3,5-bis(1,1-dimethylethyl)-2-(hydroxy-kO)benzoato-kO]-, (T-4)-
Flumatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Orladeyo
B - Blood and blood forming organs > B06 - Other hematological agents > B06A - Other hematological agents > B06AC - Drugs used in hereditary angioedema D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-[(2R,4R)-2-(4-hydroxybutoxy)-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-2H-pyran-6-yl]methanone
(2R)-4-[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
[(1S)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
(2S)-4-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
[(1R)-7-methoxy-1-(4-methoxyphenyl)sulfonyl-2-(pyridin-4-ylmethyl)-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
(2R)-4-[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2R)-4-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
(2S)-4-[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]-3-butyn-2-ol
Coelichelin(3-)
A hydroxamic acid anion obtained by deprotonation of the three hydroxamic acid groups of coelichelin.
SCH529074
SCH529074 is a potent and orally active p53 activator. SCH529074 binds specifically and conformation-dependently to p53 DBD ( DNA binding domain) with a Ki of 1-2 μM in a saturable manner. SCH529074 restores mutant p53 function and interrupts HDM2-mediated ubiquitination of wild Type p53. SCH529074 can be used for the study of non-small-cell lung carcinoma (NSCLC)[1][2].
(3r,6z,10s,14z,19r,22s,23s,26r,29r)-1,22,29-trihydroxy-10-(2-hydroxyacetyl)-2,22-dimethyl-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-diene-5,16-dione
3-[2-(3-hydroxyphenyl)ethyl]-2,4,6-tris[(4-hydroxyphenyl)methyl]-5-methoxyphenol
(8s,21r)-13,16-dimethoxy-7-methyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1,3,10,12,14(36),15(35),16,18,25,27,30(34),32-dodecaen-27-ol
(3s,4r)-6-[(3s)-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl]-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
(3r,4s)-5-[(3r)-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl]-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
5-[(2r,3s)-7-hydroxy-2-(hydroxymethyl)-4-(prop-2-en-1-yl)-6-[4-(prop-2-en-1-yl)phenoxy]-2,3-dihydro-1-benzofuran-3-yl]-5'-(prop-2-en-1-yl)-[1,1'-biphenyl]-2,2'-diol
2-hydroxy-3-[(hydroxymethylidene)amino]-n-[(6s,7r)-7,10,10-trimethyl-12-(2-methylpropyl)-2,5,9,11-tetraoxo-3-(sec-butyl)-1,4,8-trioxacyclododecan-6-yl]benzenecarboximidic acid
20,25-dimethoxy-8,23-dioxa-15,30-diazaheptacyclo[22.6.2.2⁹,¹².1³,⁷.1¹⁴,¹⁸.0²⁷,³¹.0²²,³³]hexatriaconta-1(30),3,5,7(36),9,11,14,18(33),19,21,24(32),25,27(31),34-tetradecaene-6,21-diol
(3r,4r)-5-[(3s)-10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-6-yl]-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
(8s,21s)-27-methoxy-7,22-dimethyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaen-13-ol
(4s,10s,11s,13s,14s,16r,17s,18r,21s,24s)-24-(acetyloxy)-9,9,13,16,17,21-hexamethyl-7,19-dioxo-2,8,20,22,23-pentaoxahexacyclo[12.8.1.1¹⁸,²¹.0¹,¹⁶.0⁴,¹⁰.0⁴,¹⁴]tetracos-5-en-11-yl acetate
(1r,8r,9s,10r,11r,13r,14s,15s,18s,24r,26s,27r)-10,15,26,27-tetrahydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21-dione
6-{10-hydroxy-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-5-yl}-7,9-dimethoxy-3-methyl-1h,3h,4h-naphtho[2,3-c]pyran-4,10-diol
(8s,21r)-13,27-dimethoxy-22-methyl-15,29,31-trioxa-7,22-diazaoctacyclo[19.9.3.2¹⁶,¹⁹.1⁴,³⁰.1¹⁰,¹⁴.0³,⁸.0²⁵,³³.0²⁸,³²]heptatriaconta-1,3,10,12,14(37),16,18,25(33),26,28(32),30(34),35-dodecaene
(1r,5s,7s,8r,11r,12z,14e,18s,20r,22s,23s,25r,28r)-8-hydroxy-11-[(1s)-1-hydroxyethyl]-7,25,28-trimethyl-20-[(2r)-oxiran-2-yl]-3,6,10,17,21,24-hexaoxahexacyclo[16.9.1.0¹,²².0⁵,⁷.0²⁰,²⁸.0²³,²⁵]octacosa-12,14-diene-4,16-dione
methyl 5-methoxy-12-[1-(7-methoxy-2h-1,3-benzodioxole-5-carbonyloxy)ethyl]-8,16-diazapentacyclo[10.6.1.0¹,⁹.0²,⁷.0¹⁶,¹⁹]nonadeca-2,4,6,9-tetraene-10-carboxylate
5-(acetyloxy)-4-(benzoyloxy)-2,6,10,10-tetramethyl-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl 3-phenyloxirane-2-carboxylate
10,15,26,27-tetrahydroxy-9,15-dimethyl-7,12,20,25,28-pentaoxaheptacyclo[21.4.3.1⁸,¹¹.1¹⁰,¹⁴.0¹,²⁴.0⁹,¹⁸.0¹³,¹⁸]dotriaconta-4,22-diene-6,21-dione
methyl 2-[(1r,2s,8s,9r,10s,12r,13s,14s,17s,19r,20s,21r,23z)-9-[(acetyloxy)methyl]-21-hydroxy-5,13,20-trimethyl-4,22-dioxo-3-oxaoctacyclo[14.7.1.0²,⁶.0²,¹⁴.0⁸,¹³.0¹⁰,¹².0¹⁷,¹⁹.0²⁰,²⁴]tetracosa-5,16(24)-dien-23-ylidene]propanoate
12-(acetyloxy)-2-hydroxy-2,6,10,10-tetramethyl-5-[(3-phenylprop-2-enoyl)oxy]-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate
5α-acetoxy-1β-benzoyl-8α-cinnamoyl-4α-hy-droxy-dihydroagarofuran
{"Ingredient_id": "HBIN011402","Ingredient_name": "5\u03b1-acetoxy-1\u03b2-benzoyl-8\u03b1-cinnamoyl-4\u03b1-hy-droxy-dihydroagarofuran","Alias": "NA","Ingredient_formula": "C33H38O8","Ingredient_Smile": "CC(=O)OC1C2CC(C3(C1(C(CCC3OC(=O)C=CC4=CC=CC=C4)(C)O)OC2(C)C)C)OC(=O)C5=CC=CC=C5","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "130","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
alnuside c
{"Ingredient_id": "HBIN015275","Ingredient_name": "alnuside c","Alias": "NA","Ingredient_formula": "C29H38O11","Ingredient_Smile": "CCC(C)C(=O)OC1C(C(COC1OC(CCC2=CC(=C(C=C2)O)O)CC(=O)CCC3=CC(=C(C=C3)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "961","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
baccharin
{"Ingredient_id": "HBIN017488","Ingredient_name": "baccharin","Alias": "NA","Ingredient_formula": "C29H38O11","Ingredient_Smile": "CC(C1C=CC=CC(=O)OC2CC3C4(C2(C5(CCC6(C(C5O3)O6)C)COC(=O)C7C(O7)(C(CO1)O)C)C)CO4)O","Ingredient_weight": "562.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6442;20997","PubChem_id": "117587576","DrugBank_id": "NA"}